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Supplementary Methods
Immunophenotyping
To analyze T-cells, NK-cells and their subsets by flow cytometry, a 4-color staining of fresh blood was performed followed by red blood cell lysis. Leucocytes were acquired with a BD Biosciences a FACSCalibur™ and data were analyzed with the BD CellQuest software.
PerCP-CD3 (clone SK7), PerCP-CD4 (clone SK3), PE-CD4 (clone SK3), PerCP-CD8 (clone SK1), PE-CD8 (clone SK1), APC-CD45RA (clone HI100), PE-CD27 (clone M-T271), APC-CD56 (clone B159), FITC-CD25 (clone 2A3) and FITC-CD16 (clone 3G8) were from BD Biosciences. FITC-CCR7 (clone 150503) was from R&D Systems). PE-CD127 (clone R34), and PE-NKG2D (clone ON72) were from Beckman Coulter. To analyze NK-receptor expression by flow cytometry on thawed PBMCs, an 8-color staining with mAb was performed, leucocytes were acquired with a BD Biosciences FACSCanto™ II and data were analyzed with the DIVA v6.1.3 software. FITC-DNAM-1 (clone DX11), APC-H7-CD3 (clone SK7) and PercP-Cy5.5-CD56 (clone B159) were from BD Biosciences. PE-KIR2D (clone NKVFS1), PE-NKp30 (clone AF29-4D12), APC-NKp46 (clone 9E2) and Vioblue-CD57 (clone TB03) were from Miltenyi Biotec. PE-Cy7-NKG2A (clone Z199) and APC-CD94 (clone HP-3B1) were from Beckman Coulter. BV510-CD16 (clone 3G8) was from Ozyme.
NK-cell functional assays
To analyze CD107a and CD137 expression by flow cytometry on CD3 -CD56 + NKcells in a degranulation assay, leucocytes stained with mAbs were acquired with a BD Biosciences FACSCanto™ II and data were analyzed with the DIVA v6.1.3 software. APC-CD137 (clone 4B4-1), PE-Cy7-CD56 (clone B159) and APC-H7-CD3 (clone SK7) were from BD Biosciences and BV510-CD16 (clone 3G8) was from Ozyme). For IFN- detection by flow cytometry in CD56 bright NK-cells after cytokine stimulation, IFN- intracellular staining was performed using the AlexaFluor488-labelled B27 clone (BD Biosciences). Leucocytes were acquired with a BD Biosciences FACSCanto™ II and data were analyzed with the DIVA v6.1.3 software. 
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